Actually, it has been experimentally validated that the HDAC inhibitor, suberoylanilidehydroxamic acid (SAHA), truly improved memory and cognition in an AD animal model, suggesting it as a promising treatment for AD [11]. The gene discussed is HDAC9; the disease is Alzheimer disease.